VWM
ADAP
Vigilare Wealth Management’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-28,800
| Closed | -$31.4K | – | 94 |
|
|
2023
Q1 | $31.4K | Hold |
28,800
| – | – | 0.02% | 103 |
|
|
2022
Q4 | $42K | Sell |
28,800
-8,000
| -22% | -$11.7K | 0.02% | 105 |
|
|
2022
Q3 | $40K | Sell |
36,800
-5,000
| -12% | -$5.44K | 0.05% | 103 |
|
|
2022
Q2 | $71K | Buy |
+41,800
| New | +$71K | 0.08% | 107 |
|
|
2022
Q1 | – | Sell |
-98,450
| Closed | -$369K | – | 138 |
|
|
2021
Q4 | $369K | Sell |
98,450
-1,500
| -2% | -$5.62K | 0.22% | 116 |
|
|
2021
Q3 | $517K | Buy |
99,950
+45,700
| +84% | +$236K | 0.32% | 87 |
|
|
2021
Q2 | $231K | Buy |
54,250
+16,850
| +45% | +$71.7K | 0.14% | 181 |
|
|
2021
Q1 | $199K | Buy |
37,400
+19,900
| +114% | +$106K | 0.14% | 187 |
|
|
2020
Q4 | $94K | Buy |
+17,500
| New | +$94K | 0.09% | 147 |
|